C07K 2319/73
Containing coiled-coiled motif
Official title: containing coiled-coiled motif (leucine zippers)
C07K2319/73 (Containing coiled-coiled motif) appears on 234 US grants and 395 published applications in this corpus.
Search patents in C07K- Granted patents
- 234
- Published applications
- 395
- Assignees
- 213
- Inventors
- 769
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 8 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 0 |
| 2002 | 6 | 12 |
| 2003 | 4 | 14 |
| 2004 | 4 | 7 |
| 2005 | 4 | 15 |
| 2006 | 2 | 6 |
| 2007 | 5 | 8 |
| 2008 | 9 | 5 |
| 2009 | 6 | 15 |
| 2010 | 8 | 13 |
| 2011 | 5 | 10 |
| 2012 | 7 | 17 |
| 2013 | 11 | 16 |
| 2014 | 8 | 12 |
| 2015 | 4 | 15 |
| 2016 | 14 | 26 |
| 2017 | 10 | 16 |
| 2018 | 11 | 16 |
| 2019 | 15 | 12 |
| 2020 | 6 | 24 |
| 2021 | 9 | 22 |
| 2022 | 13 | 24 |
| 2023 | 12 | 22 |
| 2024 | 13 | 30 |
| 2025 | 11 | 25 |
| 2026 | 4 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- MHC class II molecules and methods of use thereof31 Mar 2026US 12,590,139 B2University Health Network
- Galectin-1/ galectin-3 chimeras and multivalent proteins17 Mar 2026US 12,577,282 B2University of Florida Research Foundation, Inc.
- Methods and compositions relating to chimeric antigen receptors17 Mar 2026US 12,577,288 B2Trustees of Boston University
- Immune-cell targeted bispecific chimeric proteins and uses thereof20 Jan 2026US 12,527,843 B2Centre National De La Recherche Scientifique
- Leucine zipper-based compositions and methods of use30 Dec 2025US 12,509,498 B2Memorial Sloan Kettering Cancer Center
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Synthetic pathway activators27 Aug 2026US 2026/0250355 A1Arsenal Biosciences, Inc.
- Influenza neuraminidase tetramers13 Aug 2026US 2026/0234589 A1Icosavax, Inc.
- Therapeutic fusion proteins for targeting pathogenic protein aggregates for degradation16 Jul 2026US 2026/0200986 A1
Most cited
By later US patents
- Zinc finger protein derivatives and methods therefor323US 6,140,466 AThe Scripps Research Institute · 2000
- Zinc finger protein derivatives and methods therefor315US 6,242,568 B1The Scripps Research Institute · 2001
- Bispecific antibody heterodimers197US 5,932,448 AProtein Design Labs, Inc. · 1999
- Immunoglobulin chimeric monomer-dimer hybrids165US 7,348,004 B2Syntonix Pharmaceuticals, Inc. · 2008
- Monomeric and dimeric antibody-fragment fusion proteins87US 5,910,573 AMerck Patent GmbH · 1999